van Aken J, van Dongen H, le Cessie S, Allaart C F, Breedveld F C, Huizinga T W J
Department of Rheumatology, Leiden University Medical Centre, The Netherlands.
Ann Rheum Dis. 2006 Jan;65(1):20-5. doi: 10.1136/ard.2005.038471. Epub 2005 May 18.
The outcome of undifferentiated arthritis (UA) ranges from remission to rheumatoid arthritis (RA) fulfilling the American College of Rheumatology (ACR) classification criteria.
To report the outcome of UA after 1 year of follow up and compare the disease course of patients who presented with UA, but evolved into RA within 1 year (UA-RA group), with that of patients who presented with RA fulfilling the ACR criteria (RA-RA group).
The diagnosis of 330 patients who presented with UA was recorded at 1 year. The UA-RA and RA-RA groups were then followed up for 3 more years. Outcome measurements were radiographic progression, disease activity, and functional capacity.
From 330 patients who were diagnosed UA, 91 had evolved into RA at 1 year; 62 patients had presented with RA. No significant differences were detected between the UA-RA and RA-RA groups in median Sharp/van der Heijde score at baseline, radiographic progression rates, disease activity, and functional capacity. However, significantly more disease modifying antirheumatic drugs were prescribed in the RA-RA group.
The disease outcome of patients who present with UA that evolves into RA within 1 year is the same as that of patients who present with RA as measured by radiographic progression, disease activity, and functional capacity.
未分化关节炎(UA)的转归范围从缓解到符合美国风湿病学会(ACR)分类标准的类风湿关节炎(RA)。
报告UA患者随访1年后的转归,并比较出现UA但在1年内发展为RA的患者(UA-RA组)与符合ACR标准的RA患者(RA-RA组)的疾病进程。
记录330例出现UA患者1年时的诊断情况。然后对UA-RA组和RA-RA组进行为期3年的随访。转归指标包括影像学进展、疾病活动度和功能能力。
在330例诊断为UA的患者中,91例在1年时发展为RA;62例初诊时即为RA。UA-RA组和RA-RA组在基线时的Sharp/van der Heijde评分中位数、影像学进展率、疾病活动度和功能能力方面未检测到显著差异。然而,RA-RA组使用的改善病情抗风湿药物明显更多。
通过影像学进展、疾病活动度和功能能力衡量,出现UA且在1年内发展为RA的患者的疾病转归与初诊时即为RA的患者相同。